COCHLEAR LTD UNSP ADR EACH REP (CHEOY) Financials
CHEOY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 1.7 billion | 510.1 million |
| 2023-06-30 | 1.7 billion | 543.9 million |
| 2023-03-31 | 1.7 billion | 387.9 million |
| 2022-12-31 | 1.7 billion | 511.8 million |
CHEOY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 77.9 million | ? |
| 2023-06-30 | 80.8 million | 5.3 million |
| 2023-03-31 | 81.7 million | 5.3 million |
| 2022-12-31 | 23.4 million | ? |
CHEOY Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 130.4 million |
| 2023-06-30 | 52.7 million |
| 2023-03-31 | 53.4 million |
| 2022-12-31 | 48.2 million |
CHEOY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 330.6 million | - | - |
| 2023-06-30 | 368.5 million | - | 133.9 million |
| 2023-03-31 | 372.8 million | - | - |
| 2022-12-31 | 372.4 million | - | - |
CHEOY Shares Outstanding
CHEOY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 29.1 million | 86.7 million | 69.2 million | 225.2 million |
| 2023-06-30 | 9.9 million | 94.4 million | 73.2 million | 109.8 million |
| 2023-03-31 | 10.0 million | 47.8 million | 37.0 million | 111.1 million |
| 2022-12-31 | 6.9 million | 69.9 million | 63.7 million | 93.8 million |
CHEOY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 758.6 million | 194.7 million |
| 2023-06-30 | 705.3 million | 173.2 million |
| 2023-03-31 | 352.6 million | 87.6 million |
| 2022-12-31 | 608.0 million | 154.6 million |
CHEOY
Price: $108.85
Dividend Yield: 0.04%
Forward Dividend Yield: 1.25%
Payout Ratio: 88.62%
Dividend Per Share: 1.31 USD
Earnings Per Share: 1.74 USD
P/E Ratio: 67.16
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Volume: 1400
Ebitda: 260.8 millionMarket Capitalization: 13.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 15
DGR3: 26.12%
DGR5: 15.69%
DGR10: 6.92%